BIG
NVCR icon

Bellwether Investment Group’s NovoCure NVCR Stock Holding History

Bellwether Investment Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$1K – 899
2016
Q4 		$1K Buy
+100
New +$804 ﹤0.01% 950
2016
Q2 		$1K Buy
+100
New +$1.25K ﹤0.01% 619

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

Bellwether Investment Group's NVCR Position: Q1 2017 in Review

Bellwether Investment Group sold out of NovoCure (NVCR) in Q1 2017, closing a stake of 100 shares — an estimated $1K sold.

Bellwether Investment Group first reported a position in NVCR in Q2 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 71 funds tracked by Wall St. Rank hold NVCR as of Q1 2017.

  • Bellwether Investment Group reported no remaining NovoCure position as of Q1 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 100 NovoCure shares in Q1 2017, an estimated $1K.
  • Bellwether Investment Group first reported a position in NovoCure in Q2 2016 and held it in 2 quarters.
  • Bellwether Investment Group's NovoCure position peaked at $1K in Q4 2016.
  • 71 funds tracked by Wall St. Rank held NovoCure as of Q1 2017.

Based on Bellwether Investment Group's 13F filing for Q1 2017, filed 12 May 2017.